Last reviewed · How we verify
NCT04780594
Impact of the COVID-19 Pandemic on the Surgical Activity of Bellvitge University Hospital
trial testing The study evaluates all surgical patients operated, both elective scheduled and emergent cases in Covid19 in 2,530 participants. Completed in 9 December 2020.
15 May 2020
Quick facts
| Lead sponsor | Hospital Universitari de Bellvitge |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 2,530 |
| Start date | 13 February 2020 |
| Primary completion | 15 May 2020 |
| Estimated completion | 9 December 2020 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- The study evaluates all surgical patients operated, both elective scheduled and emergent cases
Conditions studied
- Covid19 — all drugs for Covid19 →
- Surgery--Complications — all drugs for Surgery--Complications →
- Nosocomial Infection — all drugs for Nosocomial Infection →
Sponsor
Hospital Universitari de Bellvitge
Who can join
18 and older, any sex, with Covid19 or Surgery--Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
COVID-19 has been a challenge for hospitals; there was an obvious need to reconvert many spaces in specific areas to attend this pathology, without forgetting the attention to other pathologies and surgery. The objective of the investigators is to evaluate the impact of this pandemic in the patients who underwent surgery in Bellvitge University Hospital, analyzing 2 periods of time: the months before the COVID-19 peak and the COVID-19 peak months.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of the SARS-CoV-2 (COVID19) pandemic on the morbidity and mortality of high risk patients undergoing surgery: a non-inferiority retrospective observational study.
Caballero-Milán M, Colomina MJ, Marin-Carcey LA, Viguera-Fernandez L, et al · · 2021 · cited 6× · PMID 34836504 · DOI 10.1186/s12871-021-01495-3
Verify or expand the search:
- PubMed search for NCT04780594
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Covid19
Currently open trials in the same condition.
- NCT03305341 — Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix · EARLY_PHASE1 · active not recruiting
- NCT06482138 — Dysfunction of Olfaction After COVID-19 Infection: Morphological and Histomolecular Investigation · NA · recruiting
- NCT04924803 — Community Developed Technology-Based Messaging to Increase COVID-19 Vaccine Uptake Among People Who Inject Drugs · NA · active not recruiting
- NCT05013632 — COVID-19 International Drug Pregnancy Registry · recruiting
- NCT04806061 — Urine Alkalinisation in COVID-19 · NA · active not recruiting
Other Hospital Universitari de Bellvitge trials
Trials by the same sponsor.
- NCT07522931 — Morphometric Study of the Female Pelvic and Lower Abdominal Retroperitoneum in Cadavers · recruiting
- NCT07155590 — Subphenotype- and Complication-guided Adjunctive Fosfomycin Therapy for Staphylococcus Aureus Bacteraemia · active not recruiting
- NCT06653192 — EUS-guided Choledochoduodenostomy vs ERCP as First Line in Malignant Distal Obstruction (CARPEDIEM Trial) · NA · recruiting
- NCT07178483 — Evaluation of Physical Capacity and Energy Requirements in Patients With Hypoxemic Acute Respiratory Failure · active not recruiting
- NCT06955221 — Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04780594 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Universitari de Bellvitge
- Last refreshed: 3 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04780594.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing